For decades, the luxury skincare industry operated as a high-margin consumer category—a commoditized market built on aesthetic masking. That era has concluded. We are currently witnessing a decisive migration of R&D capital into a new domain: Cellular Longevity. This is not a shift in marketing; it is a fundamental re-engineering of the industry's value chain, moving from cosmetic maintenance to high-barrier biological intervention. The market has bifurcated. On one side,

Cultivating our potential through science, education and regenerative innovation. Dominik Thor stands at the vanguard of longevity science — where biology, education, and enterprise converge to redefine the future of human performance. As President and Professor of Pharmacy at the Geneva College of Longevity Science (GCLS), the world’s first higher-education institution dedicated entirely to longevity, he is shaping a new academic and economic frontier. With a background spa